News
-
NIH Scientists Adapt New Brain Disease Test for Parkinson’s, Dementia with Lewy Bodies
(February 20, 2018) – National Institutes of Health scientists developing a rapid, practical test for the early diagnosis of prion diseases have modified the assay to offer the possibility of improving early diagnosis of Parkinson’s disease and dementi …
-
Breakthrough Refinement of the Parkinson’s Disease Exercise Prescription
(February 8, 2018) – A groundbreaking approach for the refinement of exercise prescriptions for people with Parkinson’s Disease is now being taught to healthcare providers. The first seminar of Exercise Prescription, Individualized Care for Parkinson’s …
-
Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis from EASE LID 2 Open-label Study
(February 8, 2018) – Adamas Pharmaceuticals, Inc. announced that subgroup analyses of Parkinson’s disease patients taking amantadine immediate release (IR) who were still experiencing dyskinesia and enrolled into EASE LID 2, the long-term, ongoing Phas …
-
Brainstem Changes Identified in Parkinson’s Disease
(January 16, 2018) – Researchers have found that patients with Parkinson’s disease (PD) have more errors in the mitochondrial DNA within the brainstem, leading to increased cell death in that area. The study’s deeper understanding into Parkinson’s dise …
-
Parkinson’s Protein Aggregates Seen in Action Destroying Neurons in Brain
(December 19, 2017) –A report by researchers from the United Kingdom, Spain, and Italy and published in the journal Science, have uncovered how aggregates of the Parkinson’s disease-associated protein alpha-synuclein damages nerve cells. The discovery …
-
Boston Scientific Receives U.S. FDA Approval for the Vercise™ Deep Brain Stimulation System
(December 11, 2017) – Boston Scientific Corporation today announced that it has received approval from the U.S. Food and Drug Administration for the Vercise™ Deep Brain Stimulation System. The platform offers physicians advanced technology to treat sym …
-
Study Shows That Parkinson’s Disease Progression Can Be Slowed with Vigorous Exercise
(December 11, 2017) – A team of researchers at Northwestern Medicine and the University of Colorado School of Medicine have found that increasing disease severity in early-stage Parkinson’s disease patients can be slowed with a few days of exercise wee …
-
Boston Scientific Receives U.S. FDA Approval for the Vercise™ Deep Brain Stimulation System
(December 11, 2017) – Boston Scientific Corporation today announced that it has received approval from the U.S. Food and Drug Administration for the Vercise™ Deep Brain Stimulation System. The platform offers physicians advanced technology to treat sym …
-
Acorda Resubmits NDA for Parkinson’s Disease Candidate Inbrija
(December 8, 2017) – Acorda Therapeutics announced that it has resubmitted the new drug application for its late stage pipeline candidate, Inbrija, to the Federal Drug Administration. Currently, the company is seeking approval for Inbrija in the United …
-
Acadia Launches Parkinson’s Campaign to Shine Light on Psychosis Symptoms
(December 1, 2017) – A new disease awareness campaign shines a light on the hallucinations and delusions that can affect half of people who have Parkinson’s disease. Sponsored by Acadia Pharmaceuticals, a TV ad and accompanying website focus on the com …